Caring and sharing knowledge

About us

BCB Medical is the Nordic market leader in gathering and analyzing clinical data. Our aim is to ensure that current and future generations live healthier lives.

We gather real-world data for medical effectiveness and treatment quality through an integrated proprietary platform. We combine, analyze and illustrate clinical data from various sources and present it in an understandable format. 

We revolutionize the way clinical data impacts people’s lives.

We offer solutions for monitoring and analyzing different disease groups. With our help, healthcare professionals around the world can provide better care for their patients and develop new forms of treatment.

Our disease-specific treatment monitoring platforms are the de facto solution in Finnish healthcare, both in public and private sector. They are in active, daily use, and currently monitor and analyze more than 100 diseases groups. 

0
Disease groups
0
Clinics
0 M
Monitored treatments
0
End users
0 M
Integration messages

Our mission

We bring data to life for the benefit of patients, so that we and the future generations can live healthier lives.

Our vision

We aim to revolutionize the way clinical data impacts people’s lives. We strive to help healthcare specialists develop new forms of treatment to improve patients’ lives.

Board of Directors

Birgitta Stymne Göransson

Chairman of the Board
Board Professional

Kari J. Mäkelä

Private investor

Erik Wästlund

Partner, Standout Capital

Antti Larsio

Senior Advisor, Sitra

Petteri Viljanen

CEO, BCB Medical

Eric Wåhlgren

Business Development Director, Attendo

Timeline

2021–
Journey to Internationalization

Expansion of Life science services to new stakeholders. The exciting journey to internationalization starts!

2019–2020
Services for Life Science

development of our services for Life Science and Research

2017–2018
Development of BCB Suite

R&D and development of BCB Suite for over 100 disease groups, including disease specific monitoring solutions for healthcare professionals, patient communication and engagement tools for patients, and state of the art analytical tools for research and reporting.

2015–2016
Significant Framework Agreement

Framework agreements with all the university hospitals and hospital districts in Finland. The agreements covers development of quality registries of over 100 disease groups supported by MyHealth solution and real-time integrations with other EHR systems in hospitals.

2013–2014
Large product portfolio

We expand our product portfolio to new medical areas: our quality registers cover nearly 30 disease groups. We also develop the integration platform, and our quality registers are integrated with hospital districts’ other patient data systems at an unprecedented rate.

2012
Co-operation with HUS

We sign framework agreements with university hospitals and hospital districts in Finland. The agreements cover quality registersfor 10 disease groups, their integration to hospital systems, and the MyHealth service.

2011
MyHealth service launched

Our quality registers are being adopted by private sector healthcare providers. We introduce the first version of MyHealth service for patients.

2007-2009
Hospital districts on board

Our first quality register is in use in nearly all Finnish hospital districts. We launch our second quality register for monitoring orthopedic arthroscopic surgery.

2005
First quality register

We launch our first quality register for artificial joint surgery and perform the first systems integrations with patient data systems.

2004
Tissue bank system spreads

Almost every tissue bank in Finland adopts our tissue bank system. We secure our first international customers in Germany, Australia and Mexico.

2003
BCB Medical is established

BCB Medical is established to provide quality monitoring solutions for tissue banks.